| NCT03405909 |
Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study |
https://ClinicalTrials.gov/show/NCT03405909 |
Recruiting |
University Hospital Erlangen |
2020-02-29 |
| NCT03356535 |
Metabolic Signature of Healthy Lifestyle and HCC |
https://ClinicalTrials.gov/show/NCT03356535 |
Completed |
International Agency for Research on Cancer |
2017-09-15 |
| NCT03356236 |
Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation |
https://ClinicalTrials.gov/show/NCT03356236 |
Recruiting |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2020-11-30 |
| NCT03300414 |
Biologic Basis of Liver Cancer From Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03300414 |
Completed |
University of California, Davis |
2018-12-14 |
| NCT03295006 |
A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC |
https://ClinicalTrials.gov/show/NCT03295006 |
Recruiting |
BTG International Inc. |
2019-11-30 |
| NCT03289273 |
Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC) |
https://ClinicalTrials.gov/show/NCT03289273 |
Active, not recruiting |
Bayer |
2022-02-01 |
| NCT03267641 |
Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03267641 |
Recruiting |
National Cancer Centre, Singapore |
2021-05-31 |
| NCT03254121 |
Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response |
https://ClinicalTrials.gov/show/NCT03254121 |
Recruiting |
Karolinska Institutet |
2021-01-01 |
| NCT03253536 |
Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03253536 |
Recruiting |
Ludwig-Maximilians - University of Munich |
2022-07-10 |
| NCT03200171 |
Effect of DAAs on Behavior of HCC in HCV Patients |
https://ClinicalTrials.gov/show/NCT03200171 |
Recruiting |
Al-Azhar University |
2019-08-31 |
| NCT03197155 |
Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence |
https://ClinicalTrials.gov/show/NCT03197155 |
Completed |
Hospices Civils de Lyon |
2017-01-31 |
| NCT03163186 |
Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial). |
https://ClinicalTrials.gov/show/NCT03163186 |
Completed |
Medical University of South Carolina |
2016-04-20 |
| NCT03162198 |
Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) |
https://ClinicalTrials.gov/show/NCT03162198 |
Completed |
Institute of Liver and Biliary Sciences, India |
2018-10-31 |
| NCT03088423 |
HCC Response Assessment by MRI After SBRT |
https://ClinicalTrials.gov/show/NCT03088423 |
Completed |
Institut de Cancérologie de Lorraine |
2013-04-01 |
| NCT03081637 |
FLNA in HCC Patients |
https://ClinicalTrials.gov/show/NCT03081637 |
Completed |
University of Milan |
2014-12-31 |
| NCT03071458 |
Mutational Landscape in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03071458 |
Completed |
Institut National de la Santé Et de la Recherche Médicale, France |
2015-05-31 |
| NCT03053596 |
LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry) |
https://ClinicalTrials.gov/show/NCT03053596 |
Completed |
Terumo Europe N.V. |
2019-04-01 |
| NCT03039322 |
Golgi Protein for HCC Diagnosis |
https://ClinicalTrials.gov/show/NCT03039322 |
Completed |
Ain Shams University |
2015-12-30 |
| NCT02990351 |
Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt |
https://ClinicalTrials.gov/show/NCT02990351 |
Completed |
Ain Shams University |
2015-12-31 |
| NCT02967848 |
Liver Function Investigation With SPECT |
https://ClinicalTrials.gov/show/NCT02967848 |
Recruiting |
Royal North Shore Hospital |
2019-12-31 |
| NCT03232593 |
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s) |
https://ClinicalTrials.gov/show/NCT03232593 |
Recruiting |
Hoffmann-La Roche |
2023-01-11 |
| NCT02941861 |
Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery |
https://ClinicalTrials.gov/show/NCT02941861 |
Completed |
Chulabhorn Hospital |
2016-08-31 |
| NCT02898415 |
Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC) |
https://ClinicalTrials.gov/show/NCT02898415 |
Completed |
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
2016-03-31 |
| NCT02880306 |
Hepatocellular Carcinoma and Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT02880306 |
Completed |
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation |
2016-03-31 |
| NCT02848638 |
Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization |
https://ClinicalTrials.gov/show/NCT02848638 |
Completed |
University of Washington |
2016-03-31 |
| NCT02838836 |
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers |
https://ClinicalTrials.gov/show/NCT02838836 |
Recruiting |
University of Missouri-Columbia |
2019-06-30 |
| NCT02809287 |
A Novel Laparoscopic Hepatectomy Posture, Left Lateral Position Plus Jackknife Position |
https://ClinicalTrials.gov/show/NCT02809287 |
Completed |
Sun Yat-sen University |
2016-01-31 |
| NCT02786342 |
Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib |
https://ClinicalTrials.gov/show/NCT02786342 |
Recruiting |
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
2020-06-30 |
| NCT02785835 |
Hepatocellular Carcinoma in HIV-infected Patients |
https://ClinicalTrials.gov/show/NCT02785835 |
Recruiting |
Hospital Universitario de Valme |
2016-12-31 |
| NCT02762721 |
Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples |
https://ClinicalTrials.gov/show/NCT02762721 |
Completed |
ArQule |
2017-04-06 |
| NCT02757846 |
Radiomics of Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02757846 |
Enrolling by invitation |
Chinese Academy of Sciences |
2022-03-31 |
| NCT02743065 |
HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China |
https://ClinicalTrials.gov/show/NCT02743065 |
Recruiting |
Fifth Affiliated Hospital, Sun Yat-Sen University |
2019-06-30 |
| NCT02730611 |
Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02730611 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2017-10-31 |
| NCT02727673 |
Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology |
https://ClinicalTrials.gov/show/NCT02727673 |
Completed |
Eastern Hepatobiliary Surgery Hospital |
2014-08-31 |
| NCT02724345 |
Postoperative Adjuvant TACE Treatment in CK18 Positive Patients |
https://ClinicalTrials.gov/show/NCT02724345 |
Completed |
Eastern Hepatobiliary Surgery Hospital |
2015-06-30 |
| NCT02685631 |
Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study |
https://ClinicalTrials.gov/show/NCT02685631 |
Recruiting |
Vanderbilt-Ingram Cancer Center |
2021-08-31 |
| NCT02670122 |
Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC |
https://ClinicalTrials.gov/show/NCT02670122 |
Completed |
Instituto de Investigación Sanitaria de la Fundación Jiménez DÃaz |
2018-11-30 |
| NCT02643173 |
Hepatocellular Carcinoma Recurrence and Anesthesia |
https://ClinicalTrials.gov/show/NCT02643173 |
Completed |
Seoul National University Bundang Hospital |
2019-06-30 |
| NCT02616692 |
HCC Patient Preferences in Japan |
https://ClinicalTrials.gov/show/NCT02616692 |
Completed |
Bayer |
2016-10-07 |
| NCT02613156 |
Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02613156 |
Completed |
Sun Yat-sen University |
2015-10-31 |
| NCT02587793 |
Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients |
https://ClinicalTrials.gov/show/NCT02587793 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2018-07-31 |
| NCT02552745 |
Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization |
https://ClinicalTrials.gov/show/NCT02552745 |
Completed |
Sun Yat-sen University |
2015-03-31 |
| NCT02541149 |
Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02541149 |
Completed |
Ain Shams University |
2015-06-30 |
| NCT02489838 |
Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02489838 |
Completed |
University of Rochester |
2019-08-07 |
| NCT02412579 |
Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation |
https://ClinicalTrials.gov/show/NCT02412579 |
Active, not recruiting |
Baylor Research Institute |
2020-05-15 |
| NCT02372162 |
Fingerprint Characterization of Advanced HCC |
https://ClinicalTrials.gov/show/NCT02372162 |
Completed |
University Hospital Tuebingen |
2019-06-01 |
| NCT02366286 |
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants |
https://ClinicalTrials.gov/show/NCT02366286 |
Active, not recruiting |
Mayo Clinic |
2022-12-31 |
| NCT02358070 |
Epidemiologic Study of Hepatocellular Carcinoma in the US |
https://ClinicalTrials.gov/show/NCT02358070 |
Completed |
Stanford University |
2016-09-01 |
| NCT02344680 |
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients |
https://ClinicalTrials.gov/show/NCT02344680 |
Active, not recruiting |
University of Alabama at Birmingham |
2024-08-31 |
| NCT02329821 |
Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection |
https://ClinicalTrials.gov/show/NCT02329821 |
Completed |
Samsung Medical Center |
2015-05-31 |
| NCT02288910 |
Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver |
https://ClinicalTrials.gov/show/NCT02288910 |
Active, not recruiting |
Rush University Medical Center |
2019-07-31 |
| NCT02269995 |
Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02269995 |
Completed |
Eisai Inc. |
2015-05-14 |
| NCT02272504 |
A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers |
https://ClinicalTrials.gov/show/NCT02272504 |
Active, not recruiting |
Wako Life Sciences |
2020-08-31 |
| NCT02173119 |
Can Quantitative MRI After cTACE Help Predict Survival ? |
https://ClinicalTrials.gov/show/NCT02173119 |
Completed |
Medical College of Wisconsin |
2018-03-07 |
| NCT02156700 |
Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors |
https://ClinicalTrials.gov/show/NCT02156700 |
Completed |
University Hospital Dubrava |
2015-12-31 |
| NCT02129829 |
PROLIFICA - West African Treatment Cohort for Hepatitis B |
https://ClinicalTrials.gov/show/NCT02129829 |
Active, not recruiting |
Imperial College London |
2020-04-01 |
| NCT02113865 |
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients |
https://ClinicalTrials.gov/show/NCT02113865 |
Completed |
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal |
2014-10-31 |
| NCT02093104 |
TACE Study-Liver Embolization Perfusion (VGH Radiology LIU) |
https://ClinicalTrials.gov/show/NCT02093104 |
Completed |
University of British Columbia |
2016-04-30 |
| NCT02073435 |
A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation |
https://ClinicalTrials.gov/show/NCT02073435 |
Completed |
Northwestern University |
2015-05-31 |
| NCT02061956 |
A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02061956 |
Completed |
Sun Yat-sen University |
2011-12-31 |
| NCT01316679 |
An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 |
https://ClinicalTrials.gov/show/NCT01316679 |
Completed |
Vanderbilt University Medical Center |
2013-01-31 |
| NCT02056041 |
Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02056041 |
Completed |
University of Milan |
2013-12-31 |
| NCT01957618 |
The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy |
https://ClinicalTrials.gov/show/NCT01957618 |
Enrolling by invitation |
National Taiwan University Hospital |
2012-01-31 |
| NCT01937286 |
Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits |
https://ClinicalTrials.gov/show/NCT01937286 |
Completed |
Ain Shams University |
2011-12-31 |
| NCT01933945 |
Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib |
https://ClinicalTrials.gov/show/NCT01933945 |
Completed |
Bayer |
2017-07-22 |
| NCT01908322 |
Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety |
https://ClinicalTrials.gov/show/NCT01908322 |
Completed |
Bayer |
2015-06-30 |
| NCT01904942 |
Study of Hepatocellular Carcinoma in Cirrhotic Patients |
https://ClinicalTrials.gov/show/NCT01904942 |
Completed |
Centre Hospitalier Universitaire Dijon |
2010-06-30 |
| NCT01839630 |
Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China |
https://ClinicalTrials.gov/show/NCT01839630 |
Completed |
Bayer |
2016-08-06 |
| NCT01825213 |
Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT |
https://ClinicalTrials.gov/show/NCT01825213 |
Completed |
Massachusetts General Hospital |
2016-10-31 |
| NCT01786980 |
The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene |
https://ClinicalTrials.gov/show/NCT01786980 |
Completed |
Eastern Hepatobiliary Surgery Hospital |
2015-12-31 |
| NCT01777698 |
Body Composition Analysis in Patients Undergoing Chemoembolization |
https://ClinicalTrials.gov/show/NCT01777698 |
Completed |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2015-08-31 |
| NCT01751763 |
Sorafenib for Residue Disease After Resection With Curative Intent |
https://ClinicalTrials.gov/show/NCT01751763 |
Completed |
Bayer |
2016-12-31 |
| NCT03349957 |
TACE for HCC by TANDEM and Idarubicin |
https://ClinicalTrials.gov/show/NCT03349957 |
Completed |
University Hospital, Montpellier |
2018-01-30 |
| NCT01657695 |
Hepatocellular Carcinoma Growth and Molecular Aggressiveness |
https://ClinicalTrials.gov/show/NCT01657695 |
Completed |
University of Modena and Reggio Emilia |
2012-05-31 |
| NCT01619475 |
Adult-to-Adult Living Donor Transplant Cohort Study |
https://ClinicalTrials.gov/show/NCT01619475 |
Completed |
Arbor Research Collaborative for Health |
2014-08-31 |
| NCT01549275 |
Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration |
https://ClinicalTrials.gov/show/NCT01549275 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2013-01-31 |
| NCT01539681 |
Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy |
https://ClinicalTrials.gov/show/NCT01539681 |
Completed |
Bayer |
2014-01-31 |
| NCT01519232 |
A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT) |
https://ClinicalTrials.gov/show/NCT01519232 |
Completed |
University of Michigan Rogel Cancer Center |
2012-06-30 |
| NCT01520779 |
Recurrence of Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT01520779 |
Completed |
Ain Shams University |
2012-11-30 |
| NCT01490203 |
Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT01490203 |
Completed |
Seoul National University Hospital |
2014-02-28 |
| NCT01481805 |
Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT01481805 |
Completed |
Samsung Medical Center |
2014-01-13 |
| NCT01482520 |
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01482520 |
Completed |
Samsung Medical Center |
2013-09-30 |
| NCT01473121 |
Hepatocellular Carcinoma Registry for Turkey (3K Trial) |
https://ClinicalTrials.gov/show/NCT01473121 |
Completed |
Bayer |
2017-06-30 |
| NCT01474694 |
Accuracy Assessment for Computer-assisted Surgical Interventions of the Liver |
https://ClinicalTrials.gov/show/NCT01474694 |
Completed |
University Hospital Inselspital, Berne |
2013-12-31 |
| NCT01446666 |
Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients |
https://ClinicalTrials.gov/show/NCT01446666 |
Completed |
Asan Medical Center |
2014-12-31 |
| NCT01416714 |
Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy |
https://ClinicalTrials.gov/show/NCT01416714 |
Recruiting |
University of Chicago |
2025-01-31 |
| NCT01411579 |
Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma |
https://ClinicalTrials.gov/show/NCT01411579 |
Completed |
University of Florence |
2012-02-29 |
| NCT01411436 |
Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan |
https://ClinicalTrials.gov/show/NCT01411436 |
Completed |
Bayer |
2014-03-31 |
| NCT01360255 |
AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE) |
https://ClinicalTrials.gov/show/NCT01360255 |
Completed |
University Hospital Freiburg |
2015-11-30 |
| NCT01361061 |
AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver |
https://ClinicalTrials.gov/show/NCT01361061 |
Completed |
University Hospital Freiburg |
2015-11-30 |
| NCT01355107 |
Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease |
https://ClinicalTrials.gov/show/NCT01355107 |
Completed |
University Hospital Freiburg |
2011-12-31 |
| NCT01349075 |
TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT01349075 |
Recruiting |
Thomas Jefferson University |
2020-12-31 |
| NCT03233360 |
Hepatocellular Carcinoma Registry in Asia |
https://ClinicalTrials.gov/show/NCT03233360 |
Recruiting |
National Cancer Centre, Singapore |
2022-03-31 |
| NCT04412161 |
Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP |
https://ClinicalTrials.gov/show/NCT04412161 |
Completed |
Inonu University |
2019-01-01 |
| NCT04371042 |
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies |
https://ClinicalTrials.gov/show/NCT04371042 |
Recruiting |
Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
2035-12-31 |
| NCT04367805 |
COVID-19 Infection in Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04367805 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2020-10-31 |
| NCT04348838 |
Prospective Cohort of Patients With Hepatocellular Carcinoma in France |
https://ClinicalTrials.gov/show/NCT04348838 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2027-09-30 |
| NCT04315883 |
Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors |
https://ClinicalTrials.gov/show/NCT04315883 |
Recruiting |
Nemours Children’s Clinic |
2029-03-01 |
| NCT04303286 |
The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04303286 |
Recruiting |
Tongji Hospital |
2020-05-31 |
| NCT04299919 |
The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive Treatment |
https://ClinicalTrials.gov/show/NCT04299919 |
Active, not recruiting |
The First Affiliated Hospital of Dalian Medical University |
2023-06-30 |
| NCT04296058 |
The Mechanism of Sox4 Transcription in Regulation of Angiogenesis in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04296058 |
Completed |
Chang Gung Memorial Hospital |
2019-03-31 |
| NCT04264754 |
Characterization of Methylation Patterns in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04264754 |
Recruiting |
Nucleix Ltd. |
2024-12-31 |
| NCT04239781 |
A Survey for Factors That Influence Postoperative Treatment Decision-making for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04239781 |
Recruiting |
Shanghai Zhongshan Hospital |
2020-06-30 |
| NCT04221347 |
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC |
https://ClinicalTrials.gov/show/NCT04221347 |
Recruiting |
Military University Hospital, Prague |
2020-12-31 |
| NCT04209491 |
Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway |
https://ClinicalTrials.gov/show/NCT04209491 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-02-01 |
| NCT04189809 |
Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations |
https://ClinicalTrials.gov/show/NCT04189809 |
Active, not recruiting |
University Hospital, Montpellier |
2020-03-01 |
| NCT04177316 |
Hypermethylation of VTRNA2-1 Promoter in HCC Outcome |
https://ClinicalTrials.gov/show/NCT04177316 |
Completed |
Chang Gung Memorial Hospital |
2019-11-15 |
| NCT04172194 |
Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular Carcinomas |
https://ClinicalTrials.gov/show/NCT04172194 |
Completed |
Centre Hospitalier Universitaire de Nice |
2014-12-31 |
| NCT04163627 |
Changing Trends in HCC Procedures |
https://ClinicalTrials.gov/show/NCT04163627 |
Recruiting |
University Hospital, Montpellier |
2021-03-01 |
| NCT04161287 |
Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACE |
https://ClinicalTrials.gov/show/NCT04161287 |
Recruiting |
Beijing 302 Hospital |
2022-11-11 |
| NCT04161911 |
A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy |
https://ClinicalTrials.gov/show/NCT04161911 |
Completed |
Bristol-Myers Squibb |
2018-11-15 |
| NCT04160897 |
Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT04160897 |
Enrolling by invitation |
Ruijin Hospital |
2020-10-31 |
| NCT04152356 |
Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04152356 |
Recruiting |
Guangxi Medical University |
2020-08-01 |
| NCT04076631 |
Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04076631 |
Recruiting |
Tongji Hospital |
2020-09-30 |
| NCT04021056 |
Observational Study on Patients With Hepatocellular Carcinoma (HCC) |
https://ClinicalTrials.gov/show/NCT04021056 |
Recruiting |
Nanfang Hospital of Southern Medical University |
2019-08-31 |
| NCT04008082 |
A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04008082 |
Recruiting |
Eisai Inc. |
2023-05-31 |
| NCT03959800 |
Molecular Basis of Pediatric Liver Cancer |
https://ClinicalTrials.gov/show/NCT03959800 |
Recruiting |
University of Pittsburgh |
2028-06-30 |
| NCT03958669 |
Fingerprint Characterization of Sorafenib Treated HCC |
https://ClinicalTrials.gov/show/NCT03958669 |
Recruiting |
University Hospital Tuebingen |
2021-06-30 |
| NCT03904667 |
Application of Watson for Oncology in Hepatocellular Carcinoma Surgery |
https://ClinicalTrials.gov/show/NCT03904667 |
Active, not recruiting |
Zhujiang Hospital |
2021-12-31 |
| NCT03894917 |
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03894917 |
Recruiting |
The University of Texas Health Science Center at San Antonio |
2020-04-30 |
| NCT03881501 |
Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03881501 |
Recruiting |
Huazhong University of Science and Technology |
2020-03-31 |
| NCT03878550 |
Case-Control Study of the Glycotestâ„¢ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03878550 |
Recruiting |
Glycotest, Inc. |
2020-12-31 |
| NCT03880721 |
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation |
https://ClinicalTrials.gov/show/NCT03880721 |
Recruiting |
Chinese PLA General Hospital |
2020-08-31 |
| NCT03852238 |
Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study) |
https://ClinicalTrials.gov/show/NCT03852238 |
Completed |
University Hospital, Bordeaux |
2013-11-14 |
| NCT03804593 |
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) |
https://ClinicalTrials.gov/show/NCT03804593 |
Completed |
Epigenomics, Inc |
2019-10-01 |
| NCT03775863 |
AFP Model and Liver Transplantation. |
https://ClinicalTrials.gov/show/NCT03775863 |
Completed |
Austral University, Argentina |
2018-12-12 |
| NCT03767764 |
Yliver as a Test to Early Diagnose HCC |
https://ClinicalTrials.gov/show/NCT03767764 |
Active, not recruiting |
Corporacion Parc Tauli |
2020-04-01 |
| NCT03756051 |
Harms of Hepatocellular Carcinoma Surveillance |
https://ClinicalTrials.gov/show/NCT03756051 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2022-04-30 |
| NCT03734068 |
Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC |
https://ClinicalTrials.gov/show/NCT03734068 |
Recruiting |
International Group of Endovascular Oncology |
2021-06-30 |
| NCT03707080 |
Direct Acting Antiviral-Post Authorization Safety Study |
https://ClinicalTrials.gov/show/NCT03707080 |
Active, not recruiting |
Target PharmaSolutions, Inc. |
2020-12-31 |
| NCT03702998 |
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population |
https://ClinicalTrials.gov/show/NCT03702998 |
Recruiting |
Chinese University of Hong Kong |
2020-07-31 |
| NCT03663114 |
A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03663114 |
Active, not recruiting |
Eisai Inc. |
2021-05-31 |
| NCT03630068 |
Computer-assisted Tumor Ablation for Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT03630068 |
Completed |
University Hospital Inselspital, Berne |
2017-12-31 |
| NCT03628651 |
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03628651 |
Completed |
Exact Sciences Corporation |
2020-03-11 |
| NCT03612726 |
The Overall Survival of Patients With Unresectable HCC in Real-life |
https://ClinicalTrials.gov/show/NCT03612726 |
Recruiting |
Humanity & Health Medical Group Limited |
2023-07-31 |
| NCT03602703 |
Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs |
https://ClinicalTrials.gov/show/NCT03602703 |
Completed |
Assiut University |
2019-09-01 |
| NCT03595345 |
A Worldwide Score for Hepatocellular Cancer and Liver Transplantation |
https://ClinicalTrials.gov/show/NCT03595345 |
Completed |
European Hepatocellular Cancer Liver Transplant Group |
2018-10-15 |
| NCT03588442 |
Prospective Surveillance for Very Early Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03588442 |
Recruiting |
Eastern Hepatobiliary Surgery Hospital |
2022-07-15 |
| NCT03551951 |
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow |
https://ClinicalTrials.gov/show/NCT03551951 |
Recruiting |
University of Missouri-Columbia |
2022-06-30 |
| NCT03534843 |
A Comparison Between Child-Pugh and Albumin-Bilirubin Scores |
https://ClinicalTrials.gov/show/NCT03534843 |
Completed |
Huazhong University of Science and Technology |
2015-08-01 |
| NCT03517332 |
Circulating Tumor DNA Exposure in Peripheral Blood |
https://ClinicalTrials.gov/show/NCT03517332 |
Recruiting |
Quantgene Inc. |
2019-12-31 |
| NCT03516890 |
Management of Spontaneous Ruptured Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03516890 |
Completed |
Huazhong University of Science and Technology |
2015-06-01 |
| NCT03507140 |
Microbiota Study in Liver Transplanted Patients |
https://ClinicalTrials.gov/show/NCT03507140 |
Recruiting |
University Hospital, Grenoble |
2021-11-01 |
| NCT03483922 |
HCC Screening Using DNA Methylation Changes in ctDNA |
https://ClinicalTrials.gov/show/NCT03483922 |
Recruiting |
HKGepitherapeutics |
2020-06-01 |
| NCT03490461 |
Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation |
https://ClinicalTrials.gov/show/NCT03490461 |
Completed |
Yonsei University |
2018-03-01 |
| NCT03476421 |
R1vascular Hepatectomy for HCC Patients |
https://ClinicalTrials.gov/show/NCT03476421 |
Completed |
Humanitas Clinical and Research Center |
2015-12-31 |
| NCT03474354 |
DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC) |
https://ClinicalTrials.gov/show/NCT03474354 |
Recruiting |
University of Athens |
2019-12-30 |
| NCT03430635 |
Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03430635 |
Completed |
Humanitas Clinical and Research Center |
2015-12-31 |
| NCT03428321 |
Small and Steatotic Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03428321 |
Completed |
University Hospital, Montpellier |
2019-11-01 |
| NCT01237132 |
East-West Hepatocellular Carcinoma Study Group |
https://ClinicalTrials.gov/show/NCT01237132 |
Completed |
University of Milan |
NA |
| NCT01213758 |
Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT |
https://ClinicalTrials.gov/show/NCT01213758 |
Completed |
University of Aarhus |
2016-04-30 |
| NCT01034865 |
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer |
https://ClinicalTrials.gov/show/NCT01034865 |
Completed |
Stanford University |
2009-06-30 |
| NCT01012011 |
Regulatory Post Marketing Surveillance Study on Nexavar® |
https://ClinicalTrials.gov/show/NCT01012011 |
Completed |
Bayer |
2015-01-31 |
| NCT00913757 |
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area |
https://ClinicalTrials.gov/show/NCT00913757 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-05-01 |
| NCT00911196 |
Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00911196 |
Completed |
GlaxoSmithKline |
2009-03-31 |
| NCT00912847 |
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00912847 |
Completed |
Chinese University of Hong Kong |
2004-04-30 |
| NCT00898755 |
Collecting and Storing Tissue From Young Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00898755 |
Completed |
Children’s Oncology Group |
2008-07-17 |
| NCT00883454 |
Estimation of Functional Liver Reserve Using Cholinesterases |
https://ClinicalTrials.gov/show/NCT00883454 |
Completed |
University of Milan |
NA |
| NCT00858000 |
Analysis of Expression of Specific Markers in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00858000 |
Completed |
GlaxoSmithKline |
2009-12-31 |
| NCT02878109 |
DCE-MRI for Assessment of Response to TACE of HCC |
https://ClinicalTrials.gov/show/NCT02878109 |
Completed |
Centre hospitalier de l’Université de Montréal (CHUM) |
2018-12-31 |
| NCT00834028 |
Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization |
https://ClinicalTrials.gov/show/NCT00834028 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2008-12-31 |
| NCT00827723 |
Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma |
https://ClinicalTrials.gov/show/NCT00827723 |
Completed |
University of Lausanne Hospitals |
2018-02-28 |
| NCT00829335 |
Anatomical Resection of the Liver for Hepatocellular Carcinoma: a New Ultrasound Guided Approach |
https://ClinicalTrials.gov/show/NCT00829335 |
Completed |
University of Milan |
2009-01-31 |
| NCT00825877 |
Long-term Follow-up of HALT-C Sustained Virological Responders |
https://ClinicalTrials.gov/show/NCT00825877 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT04415567 |
Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation |
https://ClinicalTrials.gov/show/NCT04415567 |
Completed |
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
2020-03-31 |
| NCT03042520 |
Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment |
https://ClinicalTrials.gov/show/NCT03042520 |
Recruiting |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2022-09-30 |
| NCT01518829 |
Procalcitonin in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT01518829 |
Completed |
Ain Shams University |
2012-12-31 |
| NCT00812175 |
Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib |
https://ClinicalTrials.gov/show/NCT00812175 |
Completed |
Bayer |
2012-04-30 |
| NCT03203837 |
Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere® |
https://ClinicalTrials.gov/show/NCT03203837 |
Recruiting |
Northwestern University |
2020-05-31 |
| NCT03178409 |
Combined HCC-MFCCC |
https://ClinicalTrials.gov/show/NCT03178409 |
Completed |
University of Milan |
2014-12-31 |
| NCT02834546 |
Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02834546 |
Completed |
University Hospital, Bordeaux |
2019-03-15 |
| NCT02558205 |
Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry |
https://ClinicalTrials.gov/show/NCT02558205 |
Recruiting |
Rush University Medical Center |
2020-07-31 |
| NCT04451603 |
LiverMultiScan Analysis of MRI Scans in HCC |
https://ClinicalTrials.gov/show/NCT04451603 |
Recruiting |
National Cancer Centre, Singapore |
2021-12-31 |
| NCT00792350 |
INSIGHT - Post Marketing Surveillance |
https://ClinicalTrials.gov/show/NCT00792350 |
Completed |
Bayer |
2013-10-31 |
| NCT00769730 |
Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication |
https://ClinicalTrials.gov/show/NCT00769730 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2009-02-28 |
| NCT00764140 |
Tumor Growth Factors in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00764140 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2010-04-30 |
| NCT00679692 |
Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease |
https://ClinicalTrials.gov/show/NCT00679692 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2008-03-31 |
| NCT00630240 |
Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization |
https://ClinicalTrials.gov/show/NCT00630240 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2009-02-28 |
| NCT00629421 |
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study |
https://ClinicalTrials.gov/show/NCT00629421 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2016-12-31 |
| NCT00605150 |
HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC |
https://ClinicalTrials.gov/show/NCT00605150 |
Completed |
Atrium Health |
2012-07-31 |
| NCT00600522 |
Alternative Surgical Policy for Central Liver Tumors |
https://ClinicalTrials.gov/show/NCT00600522 |
Completed |
University of Milan |
2007-01-31 |
| NCT00373347 |
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00373347 |
Recruiting |
Stanford University |
2020-12-31 |
| NCT00341705 |
The Second Multicenter Hemophilia Cohort Study |
https://ClinicalTrials.gov/show/NCT00341705 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00178867 |
A National Registry of Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00178867 |
Completed |
Vanderbilt University |
NA |
| NCT02482259 |
Assessment of Frailty in Patients With Advanced Hepatocellular Cancers |
https://ClinicalTrials.gov/show/NCT02482259 |
Completed |
Newcastle-upon-Tyne Hospitals NHS Trust |
2016-07-19 |
| NCT00096733 |
Adult-to-Adult Living Donor Liver Transplantation Study |
https://ClinicalTrials.gov/show/NCT00096733 |
Completed |
Arbor Research Collaborative for Health |
2010-08-31 |
| NCT00059267 |
Prevention of Recurrent Hepatitis B After Liver Transplantation |
https://ClinicalTrials.gov/show/NCT00059267 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2007-11-30 |